Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application

Nouv Rev Fr Hematol (1978). 1992;34(3):239-42.

Abstract

Both intact IgG and Fab fragments of a monoclonal antibody SZ-21, directed against platelet glycoprotein (GP) IIIa, inhibited binding of anti-PLA1 antibodies to PLA1-positive platelets in a dose dependent manner. Conversely, the binding capacity of the platelets for SZ-21 was decreased in the presence of anti-PLA1 antibodies. In Western blots, the determinant for SZ-21 was present on GPIIIa from either PLA1 or PLA2 homozygotes, but SZ-21 did not affect the interaction of anti-Yukb alloantibodies with their target antigen on GPIIIa. These results suggest that SZ-21 reacts with an epitope on the GPIIIa molecule very close to but not identical with that for anti-PLA1. The existence of PLA1-reactive alloantibodies in serum could be demonstrated by their competitive effect on the binding of SZ-21.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Binding, Competitive / immunology
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes / immunology
  • Humans
  • Isoantibodies / blood
  • Isoantibodies / immunology*
  • Platelet Membrane Glycoproteins / immunology
  • Titrimetry

Substances

  • Antibodies, Monoclonal
  • Epitopes
  • Isoantibodies
  • Platelet Membrane Glycoproteins